Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to Improve Long-Term Vaccine Supply

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. HONA

Go back to Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to Improve Long-Term Vaccine Supply
(NASDAQ: BNTX) Delayed: 103.76 +0.88 (0.86%)
Previous Close $102.88    52 Week High $ 
Open $102.78    52 Week Low $ 
Day High $104.82    P/E N/A 
Day Low $102.33    EPS $ 
Volume 626,060